...
首页> 外文期刊>The Indian journal of tuberculosis >DRUG RESISTANT TUBERCULOSIS IN INDIA - IS IT A MATTER OF CONCERN?
【24h】

DRUG RESISTANT TUBERCULOSIS IN INDIA - IS IT A MATTER OF CONCERN?

机译:印度的抗药性结核病-是否令人担忧?

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Control of tuberculosis in India has shown remarkable progress with the entire country being covered under the RNTCP (Revised National Tuberculosis Control Programme) by the end of March, 2006. Since the inception, the programme has evaluated more than 24 million people with suspected tuberculosis and has examined more than 100 million sputum slides. More than 6.7 million patients have been initiated on treatment that resulted in saving more than a million TB deaths. The programme has achieved the target of nearly 70 per cent of new sputum positive case detection and over 85 per cent of global target of cure rates. It is imperative that the achievements need to be sustained and maintained. While rapid programme expansion has outpaced the capacity of national and state health authorities to supervise the programme and to maintain high quality, government action is needed to reverse declines in case-detection and cure rates in some states.
机译:印度的结核病控制工作已显示出显着进展,截止2006年3月,整个国家已纳入RNTCP(修订后的国家结核病控制计划)。自该计划实施以来,该计划已评估了超过2,400万人的疑似结核病和已经检查了超过1亿个痰液载玻片。已经开始接受治疗的患者超过670万,挽救了超过100万结核病的死亡。该方案已经实现了新痰阳性病例检出率接近70%的目标,并且达到了全球治愈率目标的85%以上的目标。当务之急是必须保持和保持成就。尽管快速的项目扩展已经超过了国家和州卫生当局监督该项目并保持高质量的能力,但仍需要政府采取行动来扭转某些州的病例发现和治愈率下降的趋势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号